Inventor
MANNING ROBERT E
68 patents
⚠️ This page may combine multiple inventors who share the name “MANNING ROBERT E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEARLE & CO
38 patentsUS6943189B2Sep 13, 2005
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG CO-A reductase inhibitors
SEARLE & CO78 citations97
US5393790AFeb 28, 1995
Substituted spiro compounds for the treatment of inflammation
SEARLE & CO212 citations97
US5087634AFeb 11, 1992
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
SEARLE & CO79 citations96
US5861420AJan 19, 1999
N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
SEARLE & CO25 citations93
US5674879AOct 7, 1997
Compositions including and methods of using conformationally restricted angiotensin II antagonist
SEARLE & CO35 citations93
US5426105AJun 20, 1995
Conformationally restricted angiotensin II antagonists
SEARLE & CO37 citations93
US4923874AMay 8, 1990
Use of 8-azapurin-6-one derivatives for control of hypertension
SEARLE & CO79 citations93
US6642268B2Nov 4, 2003
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
SEARLE & CO22 citations92
US6420417B1Jul 16, 2002
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
SEARLE & CO37 citations92
US6268392B1Jul 31, 2001
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
SEARLE & CO37 citations92
US6008368ADec 28, 1999
Pharmaceutical compositions for treatment of circulatory disorders using N-substituted (α-imidazolyl-toluyl) pyrrole aniotensin II antagonists
SEARLE & CO25 citations92
US5981511ANov 9, 1999
Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
SEARLE & CO24 citations92
US5945408AAug 31, 1999
Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
SEARLE & CO27 citations92
US5451597ASep 19, 1995
Treatment of circulatory disorders using n-substituted (α-imidazolyl-toluyl) pyrrole angiotensin II antagonists
SEARLE & CO22 citations92
US5106834AApr 21, 1992
Linear free-sulfhydryl-containing oligopeptide derivatives as antihypertensive agents
SEARLE & CO37 citations90
US5441970AAug 15, 1995
Use of N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders
SEARLE & CO19 citations82
US6630497B2Oct 7, 2003
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders
SEARLE & CO7 citations74
US5416084AMay 16, 1995
Benzo-fused thiomorpholinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO2 citations74
US5411959AMay 2, 1995
1,4-Thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO2 citations74
US5411954AMay 2, 1995
Benzo-fused oxazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO3 citations74
US5411961AMay 2, 1995
Benzo-fused morpholinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO3 citations74
US5409925AApr 25, 1995
Oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO2 citations74
US5302610AApr 12, 1994
Renal-selective biphenylmethyl imidazole angiotensin II antagonists for treatment of hypertension
SEARLE & CO9 citations74
US5217985AJun 8, 1993
Renal-selective biphenylalkyl 1h-substituted-1,2,4-triazole angiotensin ii antagonists for treatment of hypertension
SEARLE & CO16 citations74
US5736579AApr 7, 1998
Substituted spiro compounds for the treatment of inflammation
SEARLE & CO8 citations72
US6858636B2Feb 22, 2005
1-phenyl imidazol-2-one biphenylmethyl compounds for treatment of circulatory disorders
SEARLE & CO2 citations63
US5484937AJan 16, 1996
N-substituted N-(α-triazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders
SEARLE & CO3 citations63
US5413998AMay 9, 1995
Benzo-fused thiazopinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5411953AMay 2, 1995
Oxazopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5411975AMay 2, 1995
Thiazolidinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5411950AMay 2, 1995
Benzo-fused oxazocinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5409945AApr 25, 1995
Benzyo-fused thiazolidinyl terminated alkylamino ethylnyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5409921AApr 25, 1995
Thiazetidinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5409922AApr 25, 1995
Thiozopinyl terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5409924AApr 25, 1995
Benzo-fused oxazobicyclo terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO1 citations63
US5373017ADec 13, 1994
Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO3 citations63
US5252591AOct 12, 1993
Pyridinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension
SEARLE & CO3 citations63
US5238952AAug 24, 1993
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
SEARLE & CO3 citations63
SANDOZ AG
5 patentsUS4544663AOct 1, 1985
Indolamine derivatives as anti-fertility agents
SANDOZ AG37 citations93
US3982020ASep 21, 1976
Substituted benzylidene hydrazines for treating hyperglycemia, obesity and inflammation
SANDOZ AG45 citations93
US3934034AJan 20, 1976
Hydroxy substituted diphenylalkyls for treatment of lipidemia
SANDOZ AG30 citations82
US3978057AAug 31, 1976
Substituted amino-hydrazinopyridazines
SANDOZ AG9 citations74
US3963780AJun 15, 1976
N,N'-disubstituted-p-phenylenediamines
SANDOZ AG10 citations74
PHARMACIA CORP
2 patentsCANNON INSTR COMPANY
2 patentsBRUNSWICK CORP
1 patentKEANE J TIMOTHY
1 patentMANNING ROBERT E
1 patentShowing the top 50 of 68 patents by PatentIndex Score.